Skip to main content
Clinical Trials/NCT00314886
NCT00314886UnknownNot Applicable

Effect of an Enriched Butyrogenic Fibres Diet on Rectal Sensitivity in Healthy Control and IBS Patients.

University Hospital, Clermont-Ferrand2 sites in 1 country15 target enrollmentStarted: January 1, 2005Last updated:
Conditions
Drugs

Trial Snapshot

Phase
Not Applicable
Sponsor
Enrollment
15
Locations
2
Primary Endpoint
Discomfort threshold to rectal distension

Study Overview

Brief Summary

Despite there being no clearcut advantages, one of the most common recommendations in IBS management is to increase the amount of dietary fibres. In some IBS patients fibres have a deleterious effect on pain and bloating. It has been shown that butyrate can increase colonic sensitivity in rats. Our purpose is to study whether butyrogenic fibres can modify rectal sensitivity and symptoms in IBS and healthy control through a modification of colonic flora.

Detailed Description

Despite there being no clearcut advantages, one of the most common recommendations in IBS management is to increase the amount of dietary fibres. In some IBS patients fibres have a deleterious effect on pain and bloating. It has been shown that butyrate can increase colonic sensitivity in rats. Our purpose is to study whether butyrogenic fibres can modify rectal sensitivity and symptoms in IBS and healthy control through a modification of colonic flora.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Crossover
Primary Purpose
Treatment
Masking
Double (Participant, Investigator)

Eligibility Criteria

Ages
18 Years to 60 Years (Adult)
Sex
Female
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • Female aged 18-60 years
  • Normal volunteers and patients with IBS assessed by Rome II criteria
  • Effective contraception
  • Affiliated to National Health Service
  • Having received oral and written information about the study
  • Having provided her written informed consent

Exclusion Criteria

  • Significant clinical or biological abnormality
  • Organic gastrointestinal disease
  • Subjects having lower than 15g/day or higher than 20g/day fibres intake
  • Antibiotic treatment during the month preceding the pre inclusion day
  • Antispasmodics, antidiarrheics, laxatives, and prokinetics during the week preceding the pre inclusion day and during all the study period.
  • Digestive surgery tract except appendectomy and cholecystectomy
  • Alcohol abuse
  • Drug addiction
  • Major psychiatric disorder

Outcomes

Primary Outcomes

Discomfort threshold to rectal distension

Secondary Outcomes

  • Quality of life (questionnaire)
  • Functional composition of colonic flora
  • Rectal sensitivity : first sensation and threshold for first sensation of the need to defecate.
  • Taxonomic composition of colonic flora
  • Fermentation profile of ingested fibre
  • Intestinal discomfort (questionnaire)

Investigators

Sponsor
University Hospital, Clermont-Ferrand
Sponsor Class
Other

Study Sites (2)

Loading locations...

Similar Trials